Peer-Led Medical Cannabis Programs: What Research Shows About Engagement and Effectiveness
Last Updated: February 2026 | Reading Time: 5 minutes
Peer-led programming — where people with lived experience of substance use are employed or trained to deliver services to their own communities — has become a standard design feature in harm reduction. The rationale is practical: peer workers build trust faster, sustain engagement better, and surface information about participant experience that clinical staff often cannot access. This article reviews what the research shows about peer-led models specifically in the context of cannabis harm reduction programs, drawing on evidence from the Canadian literature that includes programs operated by High Hopes Research Society.
Knowledge Translation from Lived Experience
A 2023 paper by Bailey, Harps, Belcher, Williams, Amos, Graham, Goulet-Stock et al., published in the International Journal of Drug Policy (DOI: 10.1016/j.drugpo.2023.104244), documents the knowledge translation process that preceded the CMAPS cannabis substitution pilots. Specifically, it describes how EIDGE (Eastside Illicit Drinkers Group for Education) and SOLID Victoria — organizations led by and for people with lived experience of illicit and non-beverage alcohol use — partnered with the CMAPS research team to co-create the educational resources that MAP sites needed to implement cannabis substitution programs. No such resources existed before this collaboration. EIDGE members, who had been using cannabis to manage alcohol consumption informally for years, were best positioned to document the benefits, risks, and cross-titration strategies relevant to long-term heavy drinkers — knowledge that clinical literature had not captured.
The paper addresses a question that institutional readers will recognize: how do you create guidance materials for a population that has been historically failed by clinical services, and for whom no established scholarly or clinical resources exist? The answer the research documents is that you involve people with that experience from the beginning — not to validate decisions already made, but as co-creators whose knowledge is treated as equivalent to clinical and methodological expertise.
This is the organizational lineage within which High Hopes Research Society operated the Vancouver cannabis substitution program: the peer infrastructure, the EIDGE relationships, and the educational frameworks had been built through years of CMAPS collaboration before the pilot began.
How Peer Data Collection Strengthens Research Quality
The Vancouver CMAPS manuscript (Bailey et al., in peer review at Drug & Alcohol Review) explicitly addresses peer data collection as a methodological strength. Peer-led program delivery and data collection by High Hopes Research Society and EIDGE contributed to immediate trust and rapport between the people responsible for data collection and participants — a dynamic the research team notes is likely to have strengthened the accuracy of self-report data.
This has a direct implication for research validity: the effect sizes documented in the Vancouver analysis are supported by a data collection method that peer involvement made more accurate. The substitution signal in the data is, at least in part, a product of the peer research infrastructure that produced it.
This finding is currently in peer review and should not be cited until accepted. It is noted here because the question of whether peer data collection improves research quality has direct relevance for institutions designing cannabis substitution program evaluations.
The DTES Model: Engagement Through Trust
The Valleriani, Haines-Saah, Capler, Bluthenthal & Socias (2020) study in the International Journal of Drug Policy documents the structural features of the High Hopes Foundation program in Vancouver that enabled high engagement. High Hopes was providing free cannabis to deeply marginalized participants — people who could not afford licensed cannabis at market prices, who lacked the documentation and regular healthcare access needed to navigate medical authorization, and who had often experienced stigma or dismissal in formal health settings.
The peer-led distribution model removed the barriers that formal access channels retained. Workers were known community members. Distribution happened in locations participants already used. There was no administrative gatekeeping that required ID, insurance, or clinical referral. The result, documented in the literature, was consistent engagement by a population that disengages from nearly everything else.
Program Satisfaction Data
The internal three-month evaluation of the High Hopes Vancouver pilot (N=40) found that 93% of participants were satisfied or very satisfied with the peer researcher model in the daily check-in and distribution process. A separate High Hopes six-month internal analysis reported 96.6% participant satisfaction with peer-led distribution specifically. These evaluations have not yet been published in a peer-reviewed journal; they are internal program evaluations. The distinction between internal evaluation data and peer-reviewed findings is an important one, and this article’s primary evidence base is the latter.
The peer-reviewed literature — Valleriani, Reddon, Bailey, and Goulet-Stock — provides the published foundation. The internal evaluation data, when formally published, will add a direct High Hopes outcome measure to the published record.
Implications for Institutional Partnerships
For healthcare institutions, harm reduction programs, and grant-making bodies evaluating peer-led cannabis program models, the research literature makes a practical case. The Bailey et al. (2023) paper establishes that lived-experience participation in resource development produces more appropriate and trusted guidance materials. The Vancouver CMAPS manuscript (in review) establishes that peer data collection improves research validity. The Valleriani et al. (2020) paper establishes that peer-led distribution achieves engagement with populations that clinical models fail to retain.
The organizational track record of High Hopes Research Society — as named program operator in peer-reviewed literature, as Health Canada-funded CMAPS partner, and as EIDGE community partner across multiple research sites — provides an institutional grounding that is verifiable in the published literature rather than self-asserted in organizational marketing materials.
This article summarizes published peer-reviewed research for informational purposes. It does not constitute medical advice. Medical cannabis requires authorization from a qualified healthcare provider. The research cited represents the findings of independent investigators and does not constitute a health claim about any specific product.
References
- Bailey, Harps, Belcher, Williams, Amos, Graham, Goulet-Stock et al. (2023). International Journal of Drug Policy, 122: 104244. DOI: 10.1016/j.drugpo.2023.104244
- Goulet-Stock, Hacksel, Scandiuzzi, Boyd, Pauly & Stockwell (2026). International Journal of Drug Policy, 147: 105083. DOI: 10.1016/j.drugpo.2025.105083
- Valleriani, Haines-Saah, Capler, Bluthenthal & Socias (2020). International Journal of Drug Policy, 79: 102737. DOI: 10.1016/j.drugpo.2020.102737